FTC Seal Federal Trade Commission
Antitrust Healthcare Issues
Antitrust Icon

Navy Blue Divider - Full

2002 COMMISSION ACTIONS
[ Other Years]

November 7, 2002

  • Health Care and Competition Law and Policy:  Notice of Public Hearings and Opportunity for Comment

November 1, 2002

October 9, 2002

  • Prepared Statement of the Federal Trade Commission Regarding Competition in the Pharmaceutical Industry
    Presented by Chairman Timothy J. Muris before the Subcommittee on Health of the Committee on Energy and Commerce, United States House of Representatives (October 9, 2002).

October 4, 2002

September 6, 2002

August 20, 2002

July 30, 2002

  • Generic Drug Entry Prior to Patent Expiration:  An FTC Study (July 2002)

July 19, 2002

  • Docket No. C-4055
    In the Matter of Aurora Associated Primary Care Physicians, L.L.C., Richard A. Patt, M.D., Gary L. Gaede, M.D., and Marcia L. Brauchler.

July 12, 2002

June 3, 2002

May 17, 2002

May 13, 2002

April 23, 2002

April 5, 2002

March 15, 2002

  • FTC v. The Hearst Trust et al. (District of the District of Columbia).
    • Letter Approving Revisions to Revised Asset Purchase Agreement Proposed by First DataBank, Inc. and Lippincott-Raven Medical, Ltd. and Lippincott Williams & Wilkins, Inc., doing business as Facts and Comparisons. [PDF 26KB]
    • News Release

January 9, 2002

  • In re: Buspirone Patent Litigation and Buspirone Antitrust Litigation (Southern District of New York)
    Memorandum of Law of Amicus Curiae The Federal Trade Commission In Opposition to Defendant's Motion to Dismiss
  • In re: First DataBank Antitrust Litigation (District of the District of Columbia)
    Federal Trade Commission's Memorandum of Points and Authorities In Opposition to Class Plaintiffs' Petition For Award of Counsel Fees and Reimbursement of Expenses

Last Updated: Thursday, February 06, 2003